Pfizer CentreOne: Ready To Help Meet Your Complex OSD Needs, Seamlessly And Simply

Innovative techniques and technologies are making it easier to harness challenging active pharmaceutical ingredients (APIs) in new medicines and increase bioavailability. However, these advances are also making the production of oral solid dosage (OSD) forms increasingly complex. The pathway from early clinical phases to the commercial market for these revolutionary therapeutics is not always straightforward and partnering with an experienced, knowledgeable CDMO can help to deliver high-quality products on-time and within budget.

Pfizer CentreOne offers state-of-the-art facilities and decades of experience in successfully delivering high-quality OSD products — including highly potent, cytotoxic, controlled, and immunosuppressant drugs — to support even the most complex OSD needs. Learn how to identify a reliable CDMO partner with services suited for your project’s needs and review how Pfizer CentreOne can help you efficiently navigate the path to market.